Cargando…
Mitochondrial Protection by PARP Inhibition
Inhibitors of the nuclear DNA damage sensor and signalling enzyme poly(ADP-ribose) polymerase (PARP) have recently been introduced in the therapy of cancers deficient in double-strand DNA break repair systems, and ongoing clinical trials aim to extend their use from other forms of cancer non-respons...
Autores principales: | Gallyas Jr., Ferenc, Sumegi, Balazs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215481/ https://www.ncbi.nlm.nih.gov/pubmed/32316192 http://dx.doi.org/10.3390/ijms21082767 |
Ejemplares similares
-
Role of Akt Activation in PARP Inhibitor Resistance in Cancer
por: Gallyas, Ferenc, et al.
Publicado: (2020) -
PARP Inhibition Attenuates Acute Kidney Allograft Rejection by Suppressing Cell Death Pathways and Activating PI-3K-Akt Cascade
por: Kalmar-Nagy, Karoly, et al.
Publicado: (2013) -
BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species
por: Sumegi, Katalin, et al.
Publicado: (2017) -
Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats
por: Eros, Krisztian, et al.
Publicado: (2017) -
PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells
por: Cseh, Anna Maria, et al.
Publicado: (2019)